As far as financing fears, let me just point out t
Post# of 72436
Or, of course, we could have a joint venture or upfront payments from a partner -- very common in biotech. Look at the deal Roche just pulled out of for another experimental antibiotic -- they put a huge amount of $$ out in advance.
Those bashers may be able to scare off some new investors but I sure don't see any of us selling -- not those of us who know what we own.